학술논문
Comment on: “Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?”
Document Type
Letter
Source
In: Clinical Pharmacokinetics . (Clinical Pharmacokinetics, 1 February 2020, 59(2):265-267)
Subject
Language
English
ISSN
11791926
03125963
03125963